文献速递神经肿瘤

免疫治疗脑肿瘤假性进展的MR灌注特征——与放化疗诱导假性进展及放射性坏死的对比研究

MR perfusion characteristics of pseudoprogression in brain tumors treated with immunotherapy - a comparative study with chemo-radiation induced pseudoprogression and radiation necrosis.
PubMed 文献 · J Neurooncol · 2024-12-17

回顾性比较16例脑肿瘤患者25个免疫治疗假性进展(iPsP)病灶与35例患者48个放化疗后假性进展及放射性坏死(ChR-PsP & RN)病灶的MR动态磁敏感对比灌注参数,iPsP组rCBVmean和rCBVmax中位数均显著高于ChR-PsP & RN组,rCBVmean 0.69可区分两组,AUC 0.71、敏感度0.72、特异度0.56。

要点

  • iPsP组rCBVmean中位数0.94,显著高于ChR-PsP & RN组0.67(p<0.01)。
  • iPsP组rCBVmax中位数1.39,显著高于ChR-PsP & RN组1.1(p=0.01)。
  • rCBVmean 0.69区分iPsP与ChR-PsP & RN的AUC 0.71、敏感度0.72、特异度0.56。

核心结论

  • 这些发现可能提示原发性和转移性脑肿瘤中,免疫治疗诱导的iPsP病灶灌注高于ChR-PsP & RN病灶。

研究设计与样本

  • 回顾性分析16例脑肿瘤患者的25个iPsP病灶和35例患者的48个ChR-PsP & RN病灶,分析MR动态磁敏感对比灌注加权成像的脑血容量(CBV),计算并比较两组rCBVmean和rCBVmax,采用Mann-Whitney U检验,并进行受试者工作特征曲线分析确定最佳截断值。

主要发现

  • iPsP组rCBVmean中位数为0.94,显著高于ChR-PsP & RN组的0.67(p<0.01)。
  • iPsP组rCBVmax中位数为1.39,显著高于ChR-PsP & RN组的1.1(p=0.01)。
  • rCBVmean 0.69区分iPsP与ChR-PsP & RN的曲线下面积为0.71,敏感度0.72,特异度0.56。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Pseudoprogression is an atypical imaging pattern of response to immunotherapy in patients with brain tumors. MR perfusion studies in this field are limited. The purpose of our study is to compare the perfusion features between pseudoprogression lesions in malignant gliomas and brain metastases treated with immunotherapy (iPsP) and the pseudoprogression after chemo-radiation therapy and radiation necrosis after radiation treatment (ChR-PsP & RN). METHODS: We retrospectively reviewed 25 iPsP lesions in 16 brain tumor patients and 48 ChR-PsP & RN lesions in 35 patients. The cerebral blood volume (CBV) of MR dynamic susceptibility contrast (DSC) perfusion weighted imaging (PWI) was analyzed, and the mean and maximal values of the ratio of CBV (rCBVmean and rCBVmax) of iPsPs and ChR-PsP & RNs were calculated and compared between these two groups using the Mann-Whitney U test. A receiver operating characteristic curve analysis was conducted, and the optimal cutoff of perfusion parameters were determined using the area under the curve, sensitivity, and specificity. RESULTS: The medians of rCBVmean and rCBVmax in iPsP group were significantly higher (0.94 and 1.39 respectively) than ChR-PsP & RN group (0.67, p < 0.01 and 1.1, p = 0.01 respectively). The rCBVmean value of 0.69 can differentiate the iPsP from ChR-PsP & RN with the area under the curve of 0.71, sensitivity of 0.72, and specificity of 0.56. CONCLUSION: These findings may suggest immunotherapy-induced higher perfusion in the iPsP lesions compared to ChR-PsP & RN lesions in primary and metastatic brain tumors.

来源:J Neurooncol,查看原文。版权归原作者所有。

引用

  1. Chen H, Tan G, Zhong L, et al. MR perfusion characteristics of pseudoprogression in brain tumors treated with immunotherapy - a comparative study with chemo-radiation induced pseudoprogression and radiation necrosis. J Neurooncol. 2024. PMID: 39688766. doi:10.1007/s11060-024-04910-0

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。